GLP-1 receptor agonists like Semaglutide and Tirzepatide (which also has another hormone called GIP) work by delaying gastric emptying
Gastrointestinal issues top the list of concerns, but gallbladder symptoms, thyroid cancer risks, and mental health questions are all part of the evolving safety profile
Now, a last-minute deal means the price hike may not be as steep as first feared
Keep reading for more information on a peptide that is making its way into wellness and anti-aging treatments
Efficacy and effectiveness of incretin-based therapies in body weight reduction Randomized controlled trials (RCT) Liraglutide, titrated up to 3.0 mg administered subcutaneously once daily (OD), was the first incretin-based AOM to be developed and launched on the market
Immunogenicity improvements, while scientifically sound, are harder to communicate in a sales conversation and often require years of real-world evidence to crystallize into prescriber behavior change